N/A
N=40
Supportive Care for Patients Newly Diagnosed With Lung Cancer
Lung Cancer
Bottom Line
View on ClinicalTrials.gov: NCT01883986 ↗Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Jan 2017
Primary outcome: Primary: Change From Baseline in Functional Assessment of Cancer Therapy-Lung Total Outcome Index Score at 3 Months — 2.7; 4.7 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Palliative Care (Behavioral)
- Age
- Adult, Older Adult · 40+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Dec 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in Functional Assessment of Cancer Therapy-Lung Total Outcome Index Score at 3 Months |
2.7; 4.7 | — |
| SECONDARY Change From Baseline in Patient Satisfaction of Care at 3 Months |
.76; 1.02 | — |
| SECONDARY Change in Baseline Quality of Clinician Communication at 3 Months |
-.18; .39 | — |
| SECONDARY Change From Baseline in Clinician Knowledge of Patient Preferences at 3 Months |
— | — |
Summary
The aims of this project are to assess the feasibility of recruiting patients and delivering a nurse-led telephone based palliative care intervention for patients with newly diagnosed lung cancer and to assess if among patients with newly diagnosed lung cancer, the investigators can estimate the effect of a nurse-led telephone based palliative care intervention on quality-of-life, symptom burden and patient satisfaction.
Eligibility Criteria
Inclusion Criteria
- Patients diagnosed at the Puget Sound Health Care System with a primary diagnosis of lung cancer,
- any cell type or stage,
- diagnosed within 8 weeks of study enrollment.
- Must have telephone access,
- ability of understand English and
- provide informed consent.
Exclusion Criteria
- Patients not eligible to participate in the study include those who are inpatients prior to randomization,
- those who are under the care of palliative care or hospice at the time of randomization,
- those who have severe mental health disorders,
- those who are unable to speak directly with the nurse over the telephone,
- or those that have the inability to provide informed consent. Investigators will recruit individuals (n=40) with lung cancer over a 12 month period.
Data sourced from ClinicalTrials.gov (NCT01883986). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.